Oncology Central

How useful are molecular assays in breast cancer in the elderly?

0

Breast cancer in the elderly represents a major public health issue, which is expected to increase in the coming decades as the population ages. Despite evidence suggesting that standard adjuvant therapy confers clinical benefit and is well tolerated overall in elderly patients, currently, in clinical practice, elderly breast cancer patients are undertreated.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.